| Prenatal Exposure to COVID-19 mRNA Vaccine BNT162b2 Induces Autism-Like Behaviors in Male Neonatal Rats: Insights into WNT and BDNF Signaling Perturbations MA Erdogan, O Gurbuz, MF Bozkurt, O Erbas Neurochemical Research, 1-15, 2024 | 3 | 2024 |
| Malign mezotelyomada kemoterapi uygulamaları M Şimşek, I Ulaş, O GÜNDÜZ Ege Tıp Dergisi 61 (1), 15-21, 2022 | 2 | 2022 |
| Endogenous retrovirus HERV-K6 and HERV-K11 polymorphisms’ analyses in head and neck squamous cell carcinoma patients E Karlik, O Gurbuz, Y Yildiz, N Gozukirmizi Meta Gene 28, 100876, 2021 | 1 | 2021 |
| Downregulation of Forkhead Transcription Factor (FOXO3a) Contributes to Tumorigenesis of Acute Myeloid Leukemia and Chronic Myeloid Leukemia. DA Odemis, H Yazici, O Gurbuz, SB Tuncer, OS Erdogan, SK Erciyas, ... UHOD: International Journal of Hematology & Oncology/Uluslararasi Hematoloji …, 2021 | 1 | 2021 |
| Abstract A48: The K-ras let-7 miRNA binding site variant and K-ras mutations in colon cancer N Dalay, Z Yalniz, O Gurbuz Molecular Cancer Therapeutics 12 (12_Supplement), A48-A48, 2014 | 1 | 2014 |
| Investigation of the methylation changes in the promoter region of RB1 gene in retinoblastoma: Unraveling the epigenetic puzzle in retinoblastoma ÖS Erdogan, DA Ödemis, ZY Kayım, O Gürbüz, SB Tuncer, S Kılıç, B Çelik, ... PATHOLOGY RESEARCH AND PRACTICE 253, 2024 | | 2024 |
| Investigation of the methylation changes in the promoter region of RB1 gene in retinoblastoma: Unraveling the epigenetic puzzle in retinoblastoma ÖŞ Erdoğan, DA Ödemiş, ZY Kayım, O Gürbüz, ŞB Tunçer, S Kılıç, B Çelik, ... Pathology-Research and Practice 253, 154939, 2024 | | 2024 |
| Malign mezotelyomada kemoterapi uygulamaları U Işık, M Şimşek, O Gürbüz DergiPark, 2022 | | 2022 |
| Analysis of copy number changes in HNSCC by MLPA N Dalay, O Gurbuz, E Baltaci, E Karaman, N Buyru Cancer Research 75 (15_Supplement), 4922-4922, 2015 | | 2015 |
| Analysis of the association of Notch pathway genes with ID4 and Ikaros gene expression in leukemia N Dalay, O Gurbuz Cancer Research 72 (8_Supplement), 4203-4203, 2012 | | 2012 |
